As of 2025-07-16, the Intrinsic Value of Kezar Life Sciences Inc (KZR) is -42.46 USD. This KZR valuation is based on the model Peter Lynch Fair Value. With the current market price of 4.62 USD, the upside of Kezar Life Sciences Inc is -1,019.07%.
Based on its market price of 4.62 USD and our intrinsic valuation, Kezar Life Sciences Inc (KZR) is overvalued by 1,019.07%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -42.46 - -42.46 | -42.46 | -1,019.07% |
| P/E | (147.59) - (202.28) | (181.31) | -4024.4% |
| DDM - Stable | (73.51) - (275.48) | (174.50) | -3877.0% |
| DDM - Multi | (88.50) - (265.72) | (133.72) | -2994.4% |
| Market Cap (mil) | 33.77 |
| Beta | 0.93 |
| Outstanding shares (mil) | 7.31 |
| Enterprise Value (mil) | 5.86 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.43% |
| Cost of Debt | 5.00% |
| WACC | 8.06% |